Nueropathic pain pain,
Conditions
Interventions
Take the test food 6 tablets daily (2 tablets each morning, noon, and night) with water or hot water for 3 months.
Sponsors
Ushida Takahiro
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1) Those who can provide written consent for participation in the study. 2) Age: 20 to 80 years old (at the time of obtaining consent) 3) Gender: Males and females who reside in Japan and can communicate in Japanese 4) Patients who have been diagnosed with intractable neuropathic pain
Exclusion criteria
Exclusion criteria: 1) Patients with current or previous diabetes mellitus 2) Those who are currently being treated with some kind of anticancer drug 3) Those who are planning to take or may take some kind of new therapeutic drug during the study period 4) Those who have a current or history of drug allergy or food allergy 5) Those who are being treated for drug dependence or drug abuse or have a history of drug dependence or drug abuse 6) Persons who regularly use health foods and supplements such as food for specified health use and food with functional properties that are expected to improve pain 7) Those who are pregnant or lactating, or those who wish to become pregnant during the study period 8) Those who have difficulty in oral intake 9) Those who are participating in other clinical trials or within one month of the end of the study 10) Those who are judged inappropriate for participation in this study by the study investigator or sub-investigator
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pain intensity(Numerous Rating Scale) | — |
Secondary
| Measure | Time frame |
|---|---|
| Pain Disability Scale(PDAS) Hospital Anxiety and Depression Scale(HADS) Pain Catastrophizing Scale(PCS) Pain Self Efficacy questionnaire(PSEQ) Athenes Insomnia Scale(AIS) Health Related Quality of Life (EQ-5D) | — |
Contacts
Public ContactYuki Terajima
Aichi Medical University
Outcome results
None listed